News

A new article in open access on SPRINTT trial is available: case finding, screening and characteristics of eligible patients

Monday, 22 October, 2018

A new article on the SPRINTT trial has been published open access in Experimental Gerontology.

It describes case finding, screening process and the characteristics of eligible participants of the SPRINTT trial.

A dedicated symposium on the SPRINTT project was held during the 14th EUGMS congress

Wednesday, 17 October, 2018

On October 11th, during the 14th EUGMS congress (Berlin, Germany), there was a dedicated symposium on the SPRINTT project.

The chairman was prof. Roberto Bernabei, the Principal Investigator of the SPRINTT project.

In this occasion, prof Francesco Landi presented the baseline data from the clinical trial, whereas dr. Emanuele Marzetti described the Biomarker Ancillary Study: rationale, methods and expected outcomes. Finally dr. Daniel Rooks talked about anti-sarcopenic drugs in the pipeline.

It is now possible to read the full text of all the 14 articles of the SPRINT-T special issue published on Aging Clinical and Experimental Research!

Tuesday, 14 November, 2017

It is a pleasure to let you know that is now possible to read the full text of each of the 14 articles on the SPRINT-T project published in a special issue of Aging Clinical and Experimental Research in 2017.

THE SPRINT-T TRIAL IS RECRUITING!!!!!!

Friday, 19 February, 2016

What are the main aims of the SPRINTT trial?

The SPRINTT project is the largest European clinical study aimed at investigating whether physical disability may be prevented in older subjects with physical frailty and sarcopenia.

Two interventions will be compared in the SPRINTT trial:

1)       A multicomponent intervention, based on physical activity and nutrition counselling, with support of specific technological devices;